75 related articles for article (PubMed ID: 25167547)
1. Multimodal entity coreference for cervical dysplasia diagnosis.
Song D; Kim E; Huang X; Patruno J; Munoz-Avila H; Heflin J; Long LR; Antani S
IEEE Trans Med Imaging; 2015 Jan; 34(1):229-45. PubMed ID: 25167547
[TBL] [Abstract][Full Text] [Related]
2. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
[TBL] [Abstract][Full Text] [Related]
3. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
Apgar BS; Brotzman G
Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
[TBL] [Abstract][Full Text] [Related]
4. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
[TBL] [Abstract][Full Text] [Related]
5. Molecular testing of human papillomavirus in cervical specimens.
Gazzaz FB
Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
[TBL] [Abstract][Full Text] [Related]
6. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
7. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.
Bollen LJ; Tjong-A-Hung SP; van der Velden J; Mol BW; ten Kate FW; ter Schegget J; Bleker OP
Gynecol Oncol; 1999 Feb; 72(2):199-201. PubMed ID: 10021301
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
9. The role of HPV testing in patients with possible high-grade cervical cytology.
Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.
Dehn D; Torkko KC; Shroyer KR
Cancer; 2007 Feb; 111(1):1-14. PubMed ID: 17219448
[TBL] [Abstract][Full Text] [Related]
11. [The value of screening using cervicography in dysplasia and neoplasms of the uterine cervix].
Coibion M; Guenier C; Miloiu A; Andry M; Bonnal JL; Nogaret JM
Rev Med Brux; 1990; 11(1-2):16-20. PubMed ID: 2406832
[TBL] [Abstract][Full Text] [Related]
12. Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep Pap test samples.
Munkhdelger J; Kim G; Wang HY; Lee D; Kim S; Choi Y; Choi E; Park S; Jin H; Park KH; Lee H
Exp Mol Pathol; 2014 Oct; 97(2):279-84. PubMed ID: 25102300
[TBL] [Abstract][Full Text] [Related]
13. [Colposcopic-histologic results in 97 patients with mild dysplasia shown by Pap test].
Crescini C; Pezzica E; Artuso A; Comerio D; Reale D; Bonaldi A
Minerva Ginecol; 1991 Nov; 43(11):509-12. PubMed ID: 1784407
[TBL] [Abstract][Full Text] [Related]
14. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
[TBL] [Abstract][Full Text] [Related]
16. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
Schiffman M; Wheeler CM; Castle PE;
J Infect Dis; 2002 Oct; 186(8):1169-72. PubMed ID: 12355370
[TBL] [Abstract][Full Text] [Related]
18. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
19. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the Papanicolaou smear and the cervigram: sensitivity, specificity, and cost analysis.
Tawa K; Forsythe A; Cove JK; Saltz A; Peters HW; Watring WG
Obstet Gynecol; 1988 Feb; 71(2):229-35. PubMed ID: 3336558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]